NFKB1 and neoplasm: For cancer treatment, Fisetin inhibits the metastatic spread of different cancer cells in tumor-bearing mice by regulating a variety of pathways, such as PI3K/AKT/mTOR, Wnt/β-catenin, NF-κB, and TRAIL/TRAIL-R [21].